Company profile: Rhythmia
1.1 - Company Overview
Company description
- Provider of medical devices for treating cardiac arrhythmia, focusing on development of a 3D cardiac mapping system to improve catheter ablation procedures for tachy-arrhythmias, such as atrial fibrillation.
Products and services
- Ayahuasca Ceremonies: Four optional plant medicine ceremonies led by trained shamans to aid personal growth and spiritual healing
- RLife Integration App: A post-retreat app offering a 90-day integration program with lifetime support to help guests continue personal development after their experience
- Rythmia Way Program: A week-long immersive experience combining ayahuasca ceremonies with modern psychology to facilitate personal transformation and healing for participants
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Rhythmia
CardioInsight
HQ: United States
Website
- Description: Provider of electrocardiographic mapping technology that non-invasively generates 3D images of the heart's electrical activity to help treat arrhythmias and congestive heart failure, and cardiac electrophysiology systems for atrial fibrillation, including noninvasive 3D mapping, pulsed field ablation, cryoballoon, temperature-controlled RF ablation, and cryoablation catheters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioInsight company profile →
Preventice Solutions
HQ: United States
Website
- Description: Provider of mobile cardiac health solutions and remote monitoring services, connecting patients, clinicians, and hospitals. Offerings include BodyGuardian wearable waterproof ECG monitors and BodyGuardian MINI PLUS for mobile cardiac telemetry; the HIPAA-compliant PatientCare platform for near-real-time data management; and service models from full-service monitoring to equipment and software purchase options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Preventice Solutions company profile →
Relypsa
HQ: United States
Website
- Description: Provider of biopharmaceutical research and development of non-absorbed polymeric drugs for cardiovascular and renal diseases, specializing in iron deficiency, nephrology, and cardio-renal therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Relypsa company profile →
Biosense Webster
HQ: United States
Website
- Description: Provider of technologies for diagnosing and treating heart rhythm disorders, partnering with clinicians to improve care for arrhythmia patients worldwide. Products include QDOT MICRO™ Catheters, THERMOCOOL SMARTTOUCH® SF Catheter, CARTO™ 3 Navigation System, and VISITAG SURPOINT™ Module. Part of the Johnson & Johnson Family of Companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosense Webster company profile →
Estech
HQ: United States
Website
- Description: Provider of medical device manufacturing and distribution focused on least invasive cardiac surgery products; privately held and based in San Ramon, California, with worldwide distribution.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Estech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Rhythmia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Rhythmia
2.2 - Growth funds investing in similar companies to Rhythmia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Rhythmia
4.2 - Public trading comparable groups for Rhythmia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →